Yes Beno very likely in the next few weeks a pharma company will offer you 3 x market cap for a share of revenue in a pre phase 2 asset that has absolutely no human efficacy data whatsoever. Sounds very very plausible.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $2.8K | 1.4M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 22716803 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 10130560 | 18 |
View Market Depth
| Last trade - 10.44am 26/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |